Medical Economics Logo
  • Physicians Money Digest

  • Physicians Financial News

  • Physicians Practice

  • Chief Healthcare Executive

All NewsCareersLegalMoneyOpinionPhysicians Financial NewsPractice ManagementTechnology
Around the PracticeBetween The LinesClinical ConsultExpert InterviewsMedical Economics PulseMedical World NewsOff The Charts PodcastsPhysician ReportPrimaryViewSlideshows
Academy
Conference CoverageConference Listing
Medical EconomicsPatient Care SupplementSponsored ContentSponsored ResourcesSupplements And Featured Publications
CME/CEJob BoardSubscribe
Financial Advisor Guide
CareersCareersCareersCareersCareersCareersCareersCareersCareers
LegalLegalLegalLegalLegal
Medical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & Technology
Opinion
Physician's Money DigestPhysician's Money DigestPhysician's Money DigestPhysician's Money Digest
PolicyPolicyPolicyPolicyPolicyPolicy
Practice FinancePractice FinancePractice FinancePractice FinancePractice FinancePractice FinancePractice Finance
Practice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice Management
Practice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice Technology
Screening
Special ReportsSpecial ReportsSpecial Reports
Spotlight -
  • The benefits of a physician MBA program
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Physician Bootcamp
  • Physician Report
CareersCareersCareersCareersCareersCareersCareersCareersCareers
LegalLegalLegalLegalLegal
Medical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & Technology
Opinion
Physician's Money DigestPhysician's Money DigestPhysician's Money DigestPhysician's Money Digest
PolicyPolicyPolicyPolicyPolicyPolicy
Practice FinancePractice FinancePractice FinancePractice FinancePractice FinancePractice FinancePractice Finance
Practice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice Management
Practice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice Technology
Screening
Special ReportsSpecial ReportsSpecial Reports
    • Academy
    • CME/CE
    • Job Board
    • Subscribe
Advertisement

News

Article

December 6, 2024

Legislation to remove financial barrier for organ donors; the Cell and Gene Therapy Access Model; trends in severe maternal morbidity – Morning Medical Update

Author(s):

Austin Littrell

Key Takeaways

  • The Expanding Support for Living Donors Act seeks to remove financial barriers by increasing reimbursement and adjusting income eligibility for donors.
  • The Cell and Gene Therapy Access Model aims to improve access to gene therapies for sickle cell disease, involving outcomes-based agreements with drug manufacturers.
  • AHRQ's report indicates a 40% rise in severe maternal morbidity from 2016 to 2021, emphasizing the need for ongoing maternal health interventions.
SHOW MORE

The top news stories in medicine today.

© SewcreamStudio - stock.adobe.com

© SewcreamStudio - stock.adobe.com

Newly introduced bill would remove financial barriers for living organ donors

Representatives Suzan DelBene (WA-01), Larry Bucshon, MD (IN-08), Kim Schrier, MD (WA-08) and Carol Miller (WV-01) have introduced the Expanding Support for Living Donors Act to address the increasingly high costs of donations. The bill would reauthorize the Living Organ Donation Reimbursement Program through 2035, increase the maximum reimbursement amount to $10,000, double the income eligibility to close to $100,000 per year and make reimbursement eligibility based on the donor’s income instead of the recipient.
“Donors give the gift of life to their fellow Americans, but for too long the system hasn’t been designed to fully support them,” DelBene said in a news release. “This legislation would remove unnecessary financial barriers that have prevented many from donating. As the transplant list continues to grow longer and longer, we must take bold steps to support living donors.”

Biden-Harris Administration working to increase access to sickle cell disease treatments

Two drug manufacturers with U.S. Food and Drug Administration (FDA)-approved gene therapies for sickle cell disease have agreed with the Centers for Medicare & Medicaid Services (CMS) to participate in the Cell and Gene Therapy Access Model, a voluntary model that will test outcomes-based agreements for cell and gene therapies to increase health outcomes and access to cell and gene therapies and decrease health care costs.

“The Cell and Gene Therapy Access Model will increase access to promising therapies that improve the chances of people living longer, healthier lives,” Chiquita Brooks-LaSure, CMS administrator, said in a news release. “This is a new frontier in providing access for people with sickle cell disease to potentially transformative treatments. CMS is pleased that these two drug manufacturers have agreed to participate in the model and work with the agency and states in providing access to potentially curative treatments that might otherwise out of reach.”

Trends in severe maternal morbidity

A recent Agency for Healthcare Research and Quality (AHRQ) report included a Healthcare Cost and Utilization Project (HCUP) statistical brief on trends in severe maternal morbidity (SMM), sorted by patient characteristics using estimates from 2016-2021. Over that span, the rate of SMM increased by 40%, from 72 cases per 10,000-delivery hospital stays in 2016 to 101.1 per 10,000-delivery hospital stays in 2021. Find the full statistical brief here.

Related Videos
Compounded GLP-1 RA drugs: Getting to know about pharmacy compounding
Compounded GLP-1 RA drugs: Getting to know about pharmacy compounding
Compounded GLP-1 RA drugs: Advice to physicians and other prescribers
Compounded GLP-1 RA drugs: Advice to physicians and other prescribers
Compounded GLP-1 RA drugs: What about prices? Are compounded drugs cheaper or more expensive than manufacturers’ versions?
Compounded GLP-1 RA drugs: What about prices? Are compounded drugs cheaper or more expensive than manufacturers’ versions?
Biden prostate cancer diagnosis: A physician expert offers his first impressions
Biden prostate cancer diagnosis: A physician expert offers his first impressions
Compounded GLP-1 RA drugs: Can pharmacists make drugs that are essentially a copy of another drug? Part 2
Compounded GLP-1 RA drugs: Can pharmacists make drugs that are essentially a copy of another drug? Part 2
Biden prostate cancer diagnosis: The newest developments for doctors
Biden prostate cancer diagnosis: The newest developments for doctors
Biden prostate cancer diagnosis: The importance of primary care and cancer detection
Biden prostate cancer diagnosis: The importance of primary care and cancer detection
Biden prostate cancer diagnosis: Surgerical options, and discovering the disease
Biden prostate cancer diagnosis: Surgerical options, and discovering the disease
Biden prostate cancer diagnosis: Treatment options
Biden prostate cancer diagnosis: Treatment options
Biden prostate cancer diagnosis: What we know so far
Biden prostate cancer diagnosis: What we know so far
Related Content
Advertisement
Primary care on the front lines of the youth mental health crisis © Liubomir - stock.adobe.com
May 20th 2025

Primary care on the front lines of the youth mental health crisis

Off the Chart: A Business of Medicine Podcast - Ep. 65: Patient autonomy with Jeffrey A. Singer, M.D.
May 19th 2025

Ep. 65: Patient autonomy with Jeffrey A. Singer, M.D.

© accenture
May 20th 2025

It’s time to bring value-based care principles to hospice

Zed Williamson and the Physician Growth Accelerator Podcast featured on Medical Economics
May 15th 2025

Vague goals are derailing your medical practice

Morning Medical Update: Nima Nassiri, M.D., with bladder transplant patient, Oscar Larrainzar © Nick Carranza - UCLA Health
May 20th 2025

World’s first human bladder transplant performed at UCLA; a potential opioid alternative without the downsides; more time spent sitting heightens risk after a cardiac event – Morning Medical Update

What you need to know about annuities: ©Zimmytws - stock.adobe.com
May 19th 2025

What you don’t know about annuities can hurt you

Related Content
Advertisement
Primary care on the front lines of the youth mental health crisis © Liubomir - stock.adobe.com
May 20th 2025

Primary care on the front lines of the youth mental health crisis

Off the Chart: A Business of Medicine Podcast - Ep. 65: Patient autonomy with Jeffrey A. Singer, M.D.
May 19th 2025

Ep. 65: Patient autonomy with Jeffrey A. Singer, M.D.

© accenture
May 20th 2025

It’s time to bring value-based care principles to hospice

Zed Williamson and the Physician Growth Accelerator Podcast featured on Medical Economics
May 15th 2025

Vague goals are derailing your medical practice

Morning Medical Update: Nima Nassiri, M.D., with bladder transplant patient, Oscar Larrainzar © Nick Carranza - UCLA Health
May 20th 2025

World’s first human bladder transplant performed at UCLA; a potential opioid alternative without the downsides; more time spent sitting heightens risk after a cardiac event – Morning Medical Update

What you need to know about annuities: ©Zimmytws - stock.adobe.com
May 19th 2025

What you don’t know about annuities can hurt you

Advertisement
Advertisement
Advertisement
x
About
Advertise
Contact Us
Editorial Staff
Job Board
Terms and Conditions
Contributor Guidelines
Privacy Policy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.